24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Earnings
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
19:57
Israel launches its first domestically built quantum computer
11:43
When technology becomes religion: How Silicon Valley is reshaping faith
10:47
Full list of Israeli high-tech funding rounds in 2024
10:00
Promise Bio raises $8.3 million in Seed funding for its precision medicine tool for diseases
More stories
Buzz
Most popular
Daily
Weekly
1
Spyware startup Paragon acquired for up to $900M by investment firm AE
2
The Wiz of GenAI security? “Lasso has the potential to be a once-in-a-decade company in cyber”
3
Promise Bio raises $8.3 million in Seed funding for its precision medicine tool for diseases
4
Israel launches new programs to address AI talent shortage
5
Israel launches its first domestically built quantum computer
More news
Earnings
20 stories about Earnings
Why did Nvidia's stellar earnings leave investors cold?
29.08.24
|
Omer Kabir
Amid soaring expectations, even record-breaking earnings can't prevent a stock slump.
Nvidia sheds $200B in market cap after underwhelming forecast, dragging AI stocks down
29.08.24
|
Reuters
Investors react to soft forecasts as tech giants see billions wiped from their market value.
From Iron Dome to David’s Sling: Rafael’s innovations power Q2 success
28.08.24
|
Yuval Azulay
Revenues jump 25% as new laser Iron Beam system nears completion.
How Zim doubled its market cap in 2024
20.08.24
|
Amir Perger
From losses to record profits: the shipping giant’s strategic comeback
Palo Alto's platformization strategy pays off: revenues soar to $8 billion
20.08.24
|
Sophie Shulman
Next-gen systems developed in Israel drive significant growth and position the company for further success.
Zim surges on strong Q2 performance and upgraded forecasts
19.08.24
|
Amir Perger
A booming container market prompts Zim to sharply upgrade its annual profit outlook.
"Airborne laser systems represent a strategic capability. It will cost just a few cents to intercept a UAV"
14.08.24
|
Yuval Azulay
Bezalel (Butzi) Machlis, CEO and President of Elbit, sees a bright future for the company after it registered record results in the second quarter.
JFrog loses a third of market cap after 2024 guidance cut
08.08.24
|
Sophie Shulman
The software company's weak forecast stands in contrast to many software companies of its size, including other Israeli firms, which have actually raised their annual forecasts.
IFF's Frutarom Dream Hits Reality, Hard
17.02.20
|
Sophie Shulman
A little over a year after IFF's $6.4 billion acquisition of Israel-based Frutarom, its annual results for 2019 fail to deliver desired boost in sales
Teva’s Small Print Gives Rise to Optimism
13.02.20
|
Sophie Shulman
The improvement CEO Kåre Shultz promised is not immediately evident in the drugmaker’s forecast for 2020, but a closer look shows Teva’s new brand drugs are starting to live up to their promise
Verint to Split Into Two Companies: Cyber and Customer Engagement
05.12.19
|
Micky Grunfeld
Verint has a market capitalization of $3.2 billion on Nasdaq; the company rose 6.88% in after-hours trading following the announcement
Lemonade Releases Financial Data Following News of Shelved IPO
17.11.19
|
Hagar Ravet
The company reported annual recurring revenue of $104.4 million and a loss ratio of 78%
Teva Up 25% on NYSE Since Third Quarter Reports
17.11.19
|
Sophie Shulman
The Israeli drugmaker closed 8.74% up on Friday after a Cleveland County District judge reduced the fine placed on Johnson and Jonhson in Oklahoma by $107 million, citing a math error made in the original ruling
Fiverr Raises 2019 Revenue Guidance on Third Quarter Reports
14.11.19
|
Tzally Greenberg
The company published its earning reports Wednesday, announcing revenues that surpassed market expectations and losses lower than the analyst consensus
WeWork Continues Downward Spiral With $1.25 Billion in Losses for 3Q 2019
14.11.19
|
CTech
The New York Times and Bloomberg first reported the company has more than doubled its losses year-over-year
Teva Is Pulling an Ace From its Sleeve in its Attempt to Reinvent Itself
11.11.19
|
Uri Tal-Tene
With one anti-cancer biosimilar launching this week and another expected to hit the market soon, Teva could be creating a new growth engine worth hundreds of millions of dollars a year
Teva Announces $1.5 Billion Debt Tender Offer
10.11.19
|
Sophie Shulman
On Thursday, the Israeli drugmaker published its third quarter reports for 2019, reporting it had cut down its net debt to $25.7 billion
Despite Losses, Teva Pays Employee Bonuses for 2018
13.08.19
|
Hezi Sternlicht
Though Teva ended 2018 with a net loss of over $2.45 billion, the company awarded its employees with bonuses worth $390 million for the fiscal year’s results
Teva Beat Analysts’ Consensus, But Its Big Battles Are Still Up Ahead
08.08.19
|
Sophie Shulman
Teva ends the second quarter of 2019 down a CFO, with negative cash flow and the threat of lawsuits that could cost billions. In his call with analysts, CEO Kare Schultz hinted at the possibility of future layoffs, but Teva still handed out $240 million worth of annual bonuses to senior executives
Teva Beats Analysts on Second Quarter Operating Income, Revenues
07.08.19
|
CTech
The company also announced chief financial officer Michael McClellan will be stepping down after two years for personal reasons related to family
More Articles
Please ensure Javascript is enabled for purposes of
website accessibility